Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2019 Jan 31;7(1). pii: E15. doi: 10.3390/vaccines7010015.

2.

Metformin as a Therapeutic Target in Endometrial Cancers.

Lee TY, Martinez-Outschoorn UE, Schilder RJ, Kim CH, Richard SD, Rosenblum NG, Johnson JM.

Front Oncol. 2018 Aug 28;8:341. doi: 10.3389/fonc.2018.00341. eCollection 2018. Review.

3.

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2018 Aug 10;6(3). pii: E54. doi: 10.3390/vaccines6030054. Review. Erratum in: Vaccines (Basel). 2019 Jan 31;7(1):.

4.

Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.

Hamilton CA, Miller A, Casablanca Y, Horowitz NS, Rungruang B, Krivak TC, Richard SD, Rodriguez N, Birrer MJ, Backes FJ, Geller MA, Quinn M, Goodheart MJ, Mutch DG, Kavanagh JJ, Maxwell GL, Bookman MA.

Gynecol Oncol. 2018 Feb;148(2):275-280. doi: 10.1016/j.ygyno.2017.11.018. Epub 2017 Nov 28.

5.

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study.

Horowitz NS, Larry Maxwell G, Miller A, Hamilton CA, Rungruang B, Rodriguez N, Richard SD, Krivak TC, Fowler JM, Mutch DG, Van Le L, Lee RB, Argenta P, Bender D, Tewari KS, Gershenson D, Java JJ, Bookman MA.

Gynecol Oncol. 2018 Jan;148(1):49-55. doi: 10.1016/j.ygyno.2017.10.011. Epub 2017 Nov 23.

6.

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.

Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD.

Cancer. 2017 May 15;123(6):985-993. doi: 10.1002/cncr.30414. Epub 2016 Nov 16.

7.

Intraperitoneal immunotherapy: historical perspectives and modern therapy.

Morano WF, Aggarwal A, Love P, Richard SD, Esquivel J, Bowne WB.

Cancer Gene Ther. 2016 Nov;23(11):373-381. doi: 10.1038/cgt.2016.49. Epub 2016 Nov 11. Review.

PMID:
27834358
8.

Postpartum Sterilization: Could Bilateral Salpingectomy Replace Tubal Ligation?

Danis RB, Della Badia CR, Richard SD.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S113. doi: 10.1016/j.jmig.2015.08.304. Epub 2015 Oct 15. No abstract available.

PMID:
27678597
9.

Comparison of Levonorgestrel Intrauterine Device and Endometrial Ablation in the Treatment of Abnormal Uterine Bleeding.

Wishall KM, Della Badia CR, Richard SD.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S110. doi: 10.1016/j.jmig.2015.08.298. Epub 2015 Oct 15. No abstract available.

PMID:
27678587
10.

Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?

Danis RB, Della Badia CR, Richard SD.

J Minim Invasive Gynecol. 2016 Sep-Oct;23(6):928-32. doi: 10.1016/j.jmig.2016.05.006. Epub 2016 May 24.

PMID:
27234430
11.

Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer.

Boisen MM, Lesnock JL, Richard SD, Beriwal S, Kelley JL, Zorn KK, Edwards RP.

Int J Gynecol Cancer. 2016 May;26(4):626-31. doi: 10.1097/IGC.0000000000000667.

PMID:
27051048
12.

Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role?

Boisen MM, Richard SD, Holtzman MP, Edwards RP, Kelley JL, Choudry MH, Bartlett D, Huang M.

J Gastrointest Oncol. 2016 Feb;7(1):10-7. doi: 10.3978/j.issn.2078-6891.2015.103.

13.

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.

Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA, Hamilton CA, Krivak TC, Maxwell GL.

J Clin Oncol. 2015 Mar 10;33(8):937-43. doi: 10.1200/JCO.2014.56.3106. Epub 2015 Feb 9.

14.

Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures.

Pereira N, Buchanan TR, Wishall KM, Kim SH, Grias I, Richard SD, Della Badia CR.

J Minim Invasive Gynecol. 2015 Feb;22(2):163-76. doi: 10.1016/j.jmig.2014.09.006. Epub 2014 Sep 11. Review.

PMID:
25218993
15.

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity.

Laskey RA, Richard SD, Smith AL, Lin JF, Beck TL, Lesnock JL, Kelley JL 3rd, Olawaiye AB, Sukumvanich P, Krivak TC.

Onco Targets Ther. 2014 Mar 21;7:469-76. doi: 10.2147/OTT.S57425. eCollection 2014.

16.

Impact of facility volume on therapy and survival for locally advanced cervical cancer.

Lin JF, Berger JL, Krivak TC, Beriwal S, Chan JK, Sukumvanich P, Monk BJ, Richard SD.

Gynecol Oncol. 2014 Feb;132(2):416-22. doi: 10.1016/j.ygyno.2013.12.013. Epub 2013 Dec 12.

PMID:
24333361
17.

Placenta membranacea with placenta accreta: radiologic diagnosis and clinical implications.

Pereira N, Yao R, Guilfoil DS, Richard SD, Plante LA.

Prenat Diagn. 2013 Dec;33(13):1293-6. doi: 10.1002/pd.4224. Epub 2013 Sep 9. No abstract available.

PMID:
24018907
18.

Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182.

Rodriguez N, Miller A, Richard SD, Rungruang B, Hamilton CA, Bookman MA, Maxwell GL, Horowitz NS, Krivak TC.

Gynecol Oncol. 2013 Sep;130(3):487-92. doi: 10.1016/j.ygyno.2013.06.017. Epub 2013 Jun 17.

PMID:
23791702
19.

Dual-console robotic surgery: a new teaching paradigm.

Smith AL, Scott EM, Krivak TC, Olawaiye AB, Chu T, Richard SD.

J Robot Surg. 2013 Jun;7(2):113-8. doi: 10.1007/s11701-012-0348-1. Epub 2012 Apr 4.

20.

Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence.

Beriwal S, Kannan N, Sukumvanich P, Richard SD, Kelley JL, Edwards RP, Olawaiye A, Krivak TC.

Gynecol Oncol. 2012 Nov;127(2):303-6. doi: 10.1016/j.ygyno.2012.08.006. Epub 2012 Aug 14.

PMID:
22902917
21.

Dual-console robotic surgery compared to laparoscopic surgery with respect to surgical outcomes in a gynecologic oncology fellowship program.

Smith AL, Krivak TC, Scott EM, Rauh-Hain JA, Sukumvanich P, Olawaiye AB, Richard SD.

Gynecol Oncol. 2012 Sep;126(3):432-6. doi: 10.1016/j.ygyno.2012.05.017. Epub 2012 May 18.

PMID:
22613352
22.

Surgery versus radiation therapy for stage IB2 cervical carcinoma: a population-based analysis.

Rungruang B, Courtney-Brooks M, Beriwal S, Zorn KK, Richard SD, Olawaiye AB, Krivak TC, Sukumvanich P.

Int J Gynecol Cancer. 2012 Mar;22(3):484-9. doi: 10.1097/IGC.0b013e31823f890f.

PMID:
22249576
23.

Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.

Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP.

Int J Gynecol Cancer. 2012 Feb;22(2):232-7. doi: 10.1097/IGC.0b013e318234f833.

PMID:
22080886
24.

Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study.

Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS.

Gynecol Oncol. 2012 Jan;124(1):53-8. doi: 10.1016/j.ygyno.2011.09.024. Epub 2011 Oct 26.

PMID:
22032836
25.

Radical hysterectomy for early stage cervical cancer: laparoscopy versus laparotomy.

Taylor SE, McBee WC Jr, Richard SD, Edwards RP.

JSLS. 2011 Apr-Jun;15(2):213-7. doi: 10.4293/108680811X13022985132218.

26.

Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian cancer: brief report.

Skaznik-Wikiel ME, Sukumvanich P, Beriwal S, Zorn KK, Kelley JL, Richard SD, Krivak TC.

Int J Gynecol Cancer. 2011 Aug;21(6):1013-7. doi: 10.1097/IGC.0b013e31821ce903.

PMID:
21792011
27.

Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.

Richard SD, Bencherif B, Edwards RP, Elishaev E, Krivak TC, Mountz JM, DeLoia JA.

Nucl Med Biol. 2011 May;38(4):485-91. doi: 10.1016/j.nucmedbio.2010.12.003. Epub 2011 Mar 3.

PMID:
21531285
28.

Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels.

Richard SD, Sukumvanich P, Lesnock JL, McBee WC, Beriwal S, Edwards RP, Zorn KK, Krivak TC.

Int J Gynecol Cancer. 2010 Aug;20(6):932-5. doi: 10.1111/IGC.0b013e3181e37a54.

PMID:
20683398
29.

Pregnancy outcomes after conservative surgical management of ovarian neoplasms treated at a single institution.

Smaldone GM, Richard SD, Edwards RP.

Int J Gynecol Cancer. 2010 Aug;20(6):926-31. doi: 10.1111/IGC.0b013e3181e5c45a.

PMID:
20683397
30.

Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis.

Teng PN, Rungruang BJ, Hood BL, Sun M, Flint MS, Bateman NW, Dhir R, Bhargava R, Richard SD, Edwards RP, Conrads TP.

J Proteome Res. 2010 Aug 6;9(8):4161-9. doi: 10.1021/pr100382v.

PMID:
20518575
31.

Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease?

Courtney-Brooks M, Sukumvanich P, Beriwal S, Zorn KK, Richard SD, Krivak TC.

Gynecol Oncol. 2010 May;117(2):308-11. doi: 10.1016/j.ygyno.2010.01.007. Epub 2010 Feb 13.

PMID:
20153883
32.

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry.

Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, Lentz SS, Levine EA, Loggie BW, Metzinger DS, Miller B, Parker L, Spellman JE, Sugarbaker PH, Edwards RP, Rai SN.

Int J Gynecol Cancer. 2010 Jan;20(1):61-9. doi: 10.1111/IGC.0b013e3181c50cde.

PMID:
20130504
33.

Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients.

Wegner RE, Beriwal S, Heron DE, Richard SD, Kelly JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC.

Brachytherapy. 2010 Jul-Sep;9(3):260-5. doi: 10.1016/j.brachy.2009.08.013. Epub 2010 Feb 1.

PMID:
20122872
34.

Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications.

Lesnock JL, Richard SD, Zorn KK, Krivak TC, Beriwal S, Sukumvanich P, McBee WC Jr, Kelley JL, Edwards RP.

Gynecol Oncol. 2010 Mar;116(3):345-50. doi: 10.1016/j.ygyno.2009.11.009. Epub 2009 Dec 2.

PMID:
19959211
35.

Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.

Richard SD, Krivak TC, Castleberry A, Beriwal S, Kelley JL 3rd, Edwards RP, Sukumvanich P.

Gynecol Oncol. 2008 Apr;109(1):43-8. doi: 10.1016/j.ygyno.2007.12.002. Epub 2008 Jan 29.

PMID:
18234297
36.

Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center.

Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ, Bartlett DL.

Ann Surg Oncol. 2008 Mar;15(3):754-63. Epub 2007 Dec 12.

PMID:
18080166
37.

Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab.

Richard SD, Krivak TC, Beriwal S, Zorn KK.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1132-5. Epub 2007 Nov 16.

PMID:
18021214
38.

Pregnancy after tumor debulking and intraperitoneal cisplatin for appendiceal carcinoid tumor.

Smaldone GM, Richard SD, Krivak TC, Kelley JL 3rd, Edwards RP.

Obstet Gynecol. 2007 Aug;110(2 Pt 2):477-9.

PMID:
17666634
39.

B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice.

Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM.

J Immunol. 1998 Oct 15;161(8):3912-8.

40.
41.

B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD.

J Exp Med. 1996 Nov 1;184(5):2049-53.

Supplemental Content

Loading ...
Support Center